SynthesisActa obstetricia et gynecologica Scandinavica2026
Transmasculine pregnancy-Occurrence, associations, and outcomes: A quantitative systematic review.
Synthesis in Acta obstetricia et gynecologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTransmasculine people experience incongruence between their gender identity and sex (registered female at birth, AFAB). Little is known about transmasculine pregnancy. This project systematically reviews all published quantitative evidence on transmasculine pregnancy occurrence, associations, and outcomes, using midwifery, obstetric, and transgender health expertise. MATERIAL AND
methodsProspero protocol CRD 42020159034. Searches combined concepts of "transmasculine," registered/assigned female at birth (AFAB), and "pregnancy," using broad, inclusive sets of MeSH terms and keywords. Database searches: Embase, Maternity and Infant Care and Medline (OVID platform), and CINAHL (EBSCO platform) were searched from 2000 to August 2024, with no language restrictions. Included study references and relevant systematic reviews were also searched.
resultsFrom 2166 citations, 44 studies were included, many of which were small and uncontrolled. PRIMARY OUTCOME: The mean proportion of transmasculine people ever having been pregnant (gravidity) was 5.6%-8.5% (47/835-321/3777, range 0%-16.3%), and the mean proportion having had births (parity) was 4.3%-8.5% (35/806-24/284, range 0%-19.1%). SECONDARY OUTCOMES: The conception rates during testosterone use were low, but insufficient to rely upon as contraception; miscarriage rates appeared high (4/5 studies had rates between 31.6 and 40%-16/40 per person, 156/493 per pregnancy). Similarly, postnatal depression rates (two studies) range 15-58% (3/20-7/12). The limited data available suggested that testosterone use before pregnancy seemed to be associated with fewer conceptions compared to never having taken it, even where transmasculine people had stopped for several months before attempting conception. Pregnancy loss seemed to be higher in those exposed to testosterone antenatally. There was no or inadequate data on most other important outcomes, including access to care, assisted reproduction, stillbirths, and obstetric and neonatal complications.
conclusionsA significant minority of transmasculine people become pregnant, including after transition. The miscarriage findings warrant further investigation. Reproductive and maternity services should adapt, although minimal information risks negative consequences for users and providers, potentially adding to the lack of trust. Better data collection and research are urgently required in order to provide effective services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.